Literature DB >> 25811317

Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.

Trung Xuan Nguyen1, Monica Abdelmalak2, Christophe Marchand2, Keli Agama2, Yves Pommier2, Mark Cushman1.   

Abstract

The structure-activity relationships and hit-to-lead optimization of dual Top1-TDP1 inhibitors in the indenoisoquinoline drug class were investigated. A series of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines were synthesized and evaluated. Several compounds displayed potent dual Top1-TDP1 inhibition. The 9-hydroxy series exhibited potencies and cytotoxicities vs Top1 that surpassed those of camptothecin (CPT), the natural alkaloid that is being used as a standard in the Top1-mediated DNA cleavage assay. One member of this series was a more potent Top1 inhibitor at a concentration of 5 nM and produced a more stable ternary drug-DNA-Top1 cleavage complex than CPT.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25811317      PMCID: PMC7747014          DOI: 10.1021/acs.jmedchem.5b00136

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  45 in total

Review 1.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

2.  DNA cleavage assay for the identification of topoisomerase I inhibitors.

Authors:  Thomas S Dexheimer; Yves Pommier
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  Tyrosyl-DNA phosphodiesterase 1 inhibitor from an anamorphic fungus.

Authors:  Motoki Takagi; Jun-ya Ueda; Ji-Hwan Hwang; Junko Hashimoto; Miho Izumikawa; Hideki Murakami; Yoshitaka Sekido; Kazuo Shin-ya
Journal:  J Nat Prod       Date:  2012-03-05       Impact factor: 4.050

4.  A systematic study of nitrated indenoisoquinolines reveals a potent topoisomerase I inhibitor.

Authors:  Andrew Morrell; Smitha Antony; Glenda Kohlhagen; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2006-12-28       Impact factor: 7.446

5.  Investigation of the lactam side chain length necessary for optimal indenoisoquinoline topoisomerase I inhibition and cytotoxicity in human cancer cell cultures.

Authors:  Andrew Morrell; Michael S Placzek; Jamin D Steffen; Smitha Antony; Keli Agama; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2007-04-03       Impact factor: 7.446

6.  Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae.

Authors:  J J Pouliot; C A Robertson; H A Nash
Journal:  Genes Cells       Date:  2001-08       Impact factor: 1.891

7.  Identification, synthesis, and biological evaluation of metabolites of the experimental cancer treatment drugs indotecan (LMP400) and indimitecan (LMP776) and investigation of isomerically hydroxylated indenoisoquinoline analogues as topoisomerase I poisons.

Authors:  Maris A Cinelli; P V Narasimha Reddy; Peng-Cheng Lv; Jian-Hua Liang; Lian Chen; Keli Agama; Yves Pommier; Richard B van Breemen; Mark Cushman
Journal:  J Med Chem       Date:  2012-12-07       Impact factor: 7.446

8.  Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay.

Authors:  Christophe Marchand; Wendy A Lea; Ajit Jadhav; Thomas S Dexheimer; Christopher P Austin; James Inglese; Yves Pommier; Anton Simeonov
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

9.  Design and synthesis of L- and D-phenylalanine derived rhodanines with novel C5-arylidenes as inhibitors of HCV NS5B polymerase.

Authors:  Bhargav A Patel; Ramalingam Krishnan; Nikhil Khadtare; K R Gurukumar; Amartya Basu; Payal Arora; Aaditya Bhatt; Maulik R Patel; Dibyendu Dana; Sanjai Kumar; Neerja Kaushik-Basu; Tanaji T Talele
Journal:  Bioorg Med Chem       Date:  2013-03-31       Impact factor: 3.641

10.  Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.

Authors:  Peng-Cheng Lv; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2014-05-06       Impact factor: 7.446

View more
  14 in total

1.  Formal [4 + 2] cycloaddition of imines with alkoxyisocoumarins.

Authors:  Claire L Jarvis; Neyra M Jemal; Spencer Knapp; Daniel Seidel
Journal:  Org Biomol Chem       Date:  2018-06-13       Impact factor: 3.876

2.  Stereochemistry and Reactivity of the HPA-Imine Mannich Intermediate.

Authors:  Daniel Polyak; Ngan Phung; Jian Liu; Robert Barrows; Thomas J Emge; Spencer Knapp
Journal:  Tetrahedron Lett       Date:  2017-08-31       Impact factor: 2.415

3.  Synthesis, anti-cancer screening and tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibition activity of novel piperidinyl sulfamides.

Authors:  Jung Ho Jun; Vineet Kumar; Thomas S Dexheimer; Iwona Wedlich; Marc C Nicklaus; Yves Pommier; Sanjay V Malhotra
Journal:  Eur J Pharm Sci       Date:  2017-10-13       Impact factor: 4.384

4.  The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo.

Authors:  V P Nikolin; N A Popova; V I Kaledin; O A Luzina; A L Zakharenko; N F Salakhutdinov; O I Lavrik
Journal:  Clin Exp Metastasis       Date:  2021-08-09       Impact factor: 5.150

5.  Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.

Authors:  Xiao-Ru Zhang; Hao-Wen Wang; Wen-Lin Tang; Yu Zhang; Hui Yang; De-Xuan Hu; Azhar Ravji; Christophe Marchand; Evgeny Kiselev; Kwabena Ofori-Atta; Keli Agama; Yves Pommier; Lin-Kun An
Journal:  J Med Chem       Date:  2018-10-31       Impact factor: 7.446

6.  Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.

Authors:  Daniel E Beck; P V Narasimha Reddy; Wei Lv; Monica Abdelmalak; Gabrielle S Tender; Sophia Lopez; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2016-04-12       Impact factor: 7.446

7.  Identification of Natural Products That Inhibit the Catalytic Function of Human Tyrosyl-DNA Phosphodiesterase (TDP1).

Authors:  Alun Bermingham; Edmund Price; Christophe Marchand; Adel Chergui; Alena Naumova; Emily L Whitson; Lauren R H Krumpe; Ekaterina I Goncharova; Jason R Evans; Tawnya C McKee; Curtis J Henrich; Yves Pommier; Barry R O'Keefe
Journal:  SLAS Discov       Date:  2017-07-11       Impact factor: 3.341

8.  Structure Modeling of Human Tyrosyl-DNA Phosphodiesterase 1 and Screening for Its Inhibitors.

Authors:  I V Gushchina; D K Nilov; A L Zakharenko; O I Lavrik; V K Švedas
Journal:  Acta Naturae       Date:  2017 Apr-Jun       Impact factor: 1.845

9.  Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay.

Authors:  Mart Toots; Mart Ustav; Andres Männik; Karl Mumm; Kaido Tämm; Tarmo Tamm; Ene Ustav; Mart Ustav
Journal:  PLoS Pathog       Date:  2017-02-09       Impact factor: 6.823

Review 10.  Tyrosyl-DNA phosphodiesterases: rescuing the genome from the risks of relaxation.

Authors:  Ajinkya S Kawale; Lawrence F Povirk
Journal:  Nucleic Acids Res       Date:  2018-01-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.